Heron Therapeutics | 税前利润



金融业
股票价格
USD
资产
USD 248.95M
现金及等价物
USD 43.07M
销售成本
USD 9.46M
流动资产
USD 229.4M
流动负债
USD 89.71M
债务
USD 149.65M
股息收益率
0
EBIT
USD -4.46M
EBITDA
USD -3.88M
员工
126
EPS每股收益
USD -0.03
股本和储备
USD 14.89M
销售毛利
USD 23.35M
债务利息支出
USD 500K
利息收入
USD 433K
贷款资金
USD 149.65M
市值
USD 192.6M
净收入
USD -4.85M
营业费用
USD 38.47M
营业利润
USD -5.66M
普通股股本
USD 1.52M
税前利润
USD -4.85M
销售收入
USD 32.81M
销售和管理费用
USD 23.35M
股票
USD 54.57M
贸易债权人
USD 12.02M
应收帐款人
USD 67.04M


税前利润 更改 日
ALKERMES USD 100.74M 4.1M 2025-09
Alnylam Pharmaceuticals USD 238.97M 274.33M 2025-09
Amarin USD -8.12M 5.34M 2025-09
ANI Pharmaceuticals USD 49.52M 39M 2025-09
Anika Therapeutics USD -3.87M 32.43M 2025-03
Arrowhead Research USD 28.27M 7.85M 2025-12
Eisai JPY 22B 7.47B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Heron Therapeutics USD -4.85M 4.39M 2024-09
Insmed USD -368.7M 48.26M 2025-09
Ligand Pharmaceuticals USD 141.14M 102M 2025-09
Merck USD 6.74B 22M 2025-09
Nektar Therapeutics USD -37.05M 15.27M 2024-09
Neurocrine Biosciences USD 291.8M 132.3M 2025-09
Omeros USD -65.12M 21.27M 2024-06
Pacira USD -1.93M 10.63M 2025-06
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Surmodics USD -7.51M 1.69M 2024-09
Ultragenyx Pharmaceutical USD -179.54M 65.54M 2025-09
Veracyte USD 18.89M 17.64M 2025-09
Vertex Pharmaceuticals USD 1.3B 15.8M 2025-09


Heron Therapeutics 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.